Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome

Luca Quartuccio; Luca Semerano; Maurizio Benucci; Marie-Christophe Boissier; Salvatore de Vita

doi:10.1016/j.jbspin.2020.03.011

Journal articles

Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome

Luca Quartuccio ^{1, *} Luca Semerano ^{2, 3} Maurizio Benucci ⁴ Marie-Christophe Boissier ^{2, 3} Salvatore de Vita ¹

* Corresponding author

1 Università degli Studi di Udine - University of Udine [Italie]

2 Li2P - Physiopathologie, cibles et thérapies de la polyarthrite rhumatoïde

3 Rheumatology Department [Bobigny]

4 San Giovanni Di Dio Hospital [Florence, Italie]

Keywords : COVID-19 Coronavirus Cytokine IL-6 SARS

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Human health and pathology / Rhumatology and musculoskeletal system

Life Sciences [q-bio] / Microbiology and Parasitology / Virology

Life Sciences [q-bio] / Human health and pathology / Emerging diseases

Complete list of metadata

https://www.hal.inserm.fr/inserm-02559209
Contributor : Myriam Bodescot <>
Submitted on : Thursday, April 30, 2020 - 11:32:01 AM
Last modification on : Wednesday, May 19, 2021 - 2:26:03 PM

Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome

Links full text

Identifiers

Collections

Citation

Export

Metrics

96

Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome

Links full text

Identifiers

Collections

Citation

Export

Share

Metrics

96